It's not easy being green: The viridans group streptococci, with a focus on pediatric clinical manifestations

Journal of Clinical Microbiology

Volumn 48, Issue 11, 2010, Pages 3829-3835

  Doern, Christopher D ^a   Burnham, Carey Ann D ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL RNA; CEFEPIME; CEFTRIAXONE; CLARITHROMYCIN; CYTARABINE; DAPTOMYCIN; ERYTHROMYCIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; MIKAMYCIN B; PENICILLIN DERIVATIVE; RNA 16S; VANCOMYCIN;

ABSCESS; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTHRALGIA; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOCHEMISTRY; BLOOD CULTURE; CENTRAL NERVOUS SYSTEM DISEASE; CHILDHOOD CANCER; CHILDHOOD MORTALITY; CLINICAL ASSESSMENT; CONGENITAL DISORDER; CYANOTIC HEART DISEASE; CYSTIC FIBROSIS; DIAPHORESIS; DNA DNA HYBRIDIZATION; FATIGUE; GASTROINTESTINAL TOXICITY; GENE SEQUENCE; HOSPITAL ADMISSION; HUMAN; INFECTION COMPLICATION; INFECTION RISK; LUNG INFECTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENINGOMYELOCELE; MICROBIOLOGY; MORTALITY; MUCOSA INFLAMMATION; MYALGIA; NEUTROPENIA; NONHUMAN; PATHOGENESIS; PEDIATRICS; PENICILLIN RESISTANCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RIGOR; SHORT SURVEY; SKIN INFECTION; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS BOVIS; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS; STREPTOCOCCUS VIRIDANS INFECTION; TAXONOMY; TOXIC SHOCK SYNDROME; VIRIDANS STREPTOCOCCAL SHOCK SYNDROME; WEAKNESS; WEIGHT REDUCTION;

BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, MICROBIAL; ENDOCARDITIS; HUMANS; PERITONITIS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS MITIS;

EID: 78049517994     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01563-10     Document Type: Short Survey

References (55)

1. Arbique, J. C., C. Poyart, P. Trieu-Cuot, G. Quesne, G. Carvalho Mda, A. G. Steigerwalt, R. E. Morey, D. Jackson, R. J. Davidson, and R. R. Facklam. 2004. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J. Clin. Microbiol. 42:4686-4696.
2. Bantar, C., L. Fernandez Canigia, S. Relloso, A. Lanza, H. Bianchini, and J. Smayevsky. 1996. Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens. J. Clin. Microbiol. 34:2020-2022.
3. Beck, M., R. Frodl, and G. Funke. 2008. Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli. J. Clin. Microbiol. 46:2966-2972.
4. Belko, J., D. A. Goldmann, A. Macone, and A. K. Zaidi. 2002. Clinically significant infections with organisms of the Streptococcus milleri group. Pediatr. Infect. Dis. J. 21:715-723.
5. Brigante, G., F. Luzzaro, A. Bettaccini, G. Lombardi, F. Meacci, B. Pini, S. Stefani, and A. Toniolo. 2006. Use of the Phoenix automated system for identification of Streptococcus and Enterococcus spp. J. Clin. Microbiol. 44:3263-3267. (Pubitemid 44413762)
6. Brigante, G. R., F. A. Luzzaro, B. Pini, G. Lombardi, G. Sokeng, and A. Q. Toniolo. 2007. Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system. BMC Microbiol. 7:46.
7. Bruckner, L. B., D. N. Korones, T. Karnauchow, D. J. Hardy, and F. Gigliotti. 2002. High incidence of penicillin resistance among alpha-hemolytic streptococci isolated from the blood of children with cancer. J. Pediatr. 140:20-26.
8. Castanheira, M., R. N. Jones, and H. S. Sader. 2008. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006). Diagn. Microbiol. Infect. Dis. 61:235-239.
9. Christner, M., H. Rohde, M. Wolters, I. Sobottka, K. Wegscheider, and M. Aepfelbacher. 2010. Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting. J. Clin. Microbiol. 48:1584-1591.
10. Claridge, J. E., III, S. Attorri, D. M. Musher, J. Hebert, and S. Dunbar. 2001. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess. Clin. Infect. Dis. 32:1511-1515.
11. Coykendall, A. L. 1989. Classification and identification of the viridans streptococci. Clin. Microbiol. Rev. 2:315-328.
12. Day, M. D., K. Gauvreau, S. Shulman, and J. W. Newburger. 2009. Characteristics of children hospitalized with infective endocarditis. Circulation 119:865-870.
13. Duan, K., C. Dammel, J. Stein, H. Rabin, and M. G. Surette. 2003. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol. Microbiol. 50:1477-1491.
14. Facklam, R. 2002. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin. Microbiol. Rev. 15:613-630.
15. Ferrieri, P., M. H. Gewitz, M. A. Gerber, J. W. Newburger, A. S. Dajani, S. T. Shulman, W. Wilson, A. F. Bolger, A. Bayer, M. E. Levison, T. J. Pallasch, T. W. Gage, and K. A. Taubert. 2002. Unique features of infective endocarditis in childhood. Pediatrics 109:931-943.
16. Ferroni, A., S. Suarez, J. L. Beretti, B. Dauphin, E. Bille, J. Meyer, M. E. Bougnoux, A. Alanio, P. Berche, and X. Nassif. 2010. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 48:1542-1548.
17. Friedrichs, C., A. C. Rodloff, G. S. Chhatwal, W. Schellenberger, and K. Eschrich. 2007. Rapid identification of viridans streptococci by mass spectrometric discrimination. J. Clin. Microbiol. 45:2392-2397.
18. Gamis, A. S., W. B. Howells, J. DeSwarte-Wallace, J. H. Feusner, J. D. Buckley, and W. G. Woods. 2000. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's Cancer Group study CCG-2891. J. Clin. Oncol. 18:1845-1855.
19. Gassas, A., R. Grant, S. Richardson, L. L. Dupuis, J. Doyle, U. Allen, O. Abla, and L. Sung. 2004. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J. Clin. Oncol. 22:1222-1227.
20. Gavin, P. J., R. B. Thomson, Jr., S. J. Horng, and R. Yogev. 2003. Neonatal sepsis caused by Streptococcus bovis variant (biotype II/2): report of a case and review. J. Clin. Microbiol. 41:3433-3435.
21. Gavin, P. J., J. R. Warren, A. A. Obias, S. M. Collins, and L. R. Peterson. 2002. Evaluation of the Vitek 2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae. Eur. J. Clin. Microbiol. Infect. Dis. 21:869-874.
22. Geggel, R. L. 2004. Conditions leading to pediatric cardiology consultation in a tertiary academic hospital. Pediatrics 114:e409-e417.
23. Ghaffar, F., I. R. Friedland, K. Katz, L. S. Muniz, J. L. Smith, P. Davis, J. Reynolds, and G. H. McCracken, Jr. 1999. Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. J. Pediatr. 135:618-623.
24. Griffith, G. C., and D. C. Levinson. 1949. Subacute bacterial endocarditis; a report on 57 patients treated with massive doses of penicillin. Calif. Med. 71:403-408.
25. Guiot, H. F., J. W. van der Meer, P. J. van den Broek, R. Willemze, and R. van Furth. 1992. Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole. Ann. Hematol. 64:260-265.
26. Hirakata, Y., J. Matsuda, M. Nakano, T. Hayashi, S. Tozaka, T. Takezawa, H. Takahashi, Y. Higashiyama, Y. Miyazaki, S. Kamihira, and S. Kohno. 2005. Evaluation of the BD Phoenix Automated Microbiology System SMIC/ID panel for identification and antimicrobial susceptibility testing of Streptococcus spp. Diagn. Microbiol. Infect. Dis. 53:169-173.
27. Husain, E., S. Whitehead, A. Castell, E. E. Thomas, and D. P. Speert. 2005. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility. Pediatr. Infect. Dis. J. 24:563-566.
28. Innings, A., M. Krabbe, M. Ullberg, and B. Herrmann. 2005. Identification of 43 Streptococcus species by pyrosequencing analysis of the rnpB gene. J. Clin. Microbiol. 43:5983-5991.
29. Jackson, D. S., D. F. Welch, D. A. Pickett, G. M. Mukwaya, and T. L. Kuhls. 1995. Suppurative infections in children caused by non-beta-hemolytic members of the Streptococcus milleri group. Pediatr. Infect. Dis. J. 14:80-82.
30. Johnson, D. H., A. Rosenthal, and A. S. Nadas. 1975. A forty-year review of bacterial endocarditis in infancy and childhood. Circulation 51:581-588.
31. Kastner, U., and J. P. Guggenbichler. 2001. Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Infection 29:251-256.
32. Kikuchi, K., T. Enari, K. Totsuka, and K. Shimizu. 1995. Comparison of phenotypic characteristics, DNA-DNA hybridization results, and results with a commercial rapid biochemical and enzymatic reaction system for identification of viridans group streptococci. J. Clin. Microbiol. 33:1215-1222.
33. Lu, H. Z., X. H. Weng, B. Zhu, H. Li, Y. K. Yin, Y. X. Zhang, D. W. Haas, and Y. W. Tang. 2003. Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis. J. Clin. Microbiol. 41:3051-3055.
34. Lucas, V. S., D. Beighton, G. J. Roberts, and S. J. Challacombe. 1997. Changes in the oral streptococcal flora of children undergoing allogeneic bone marrow transplantation. J. Infect. 35:135-141.
35. Malhotra-Kumar, S., C. Lammens, S. Coenen, K. Van Herck, and H. Goossens. 2007. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 369:482-490.
36. Martin, J. M., W. H. Neches, and E. R. Wald. 1997. Infective endocarditis: 35 years of experience at a children's hospital. Clin. Infect. Dis. 24:669-675.
37. Martino, R., M. Subira, R. Manteiga, I. Badell, B. Argiles, A. Sureda, and S. Brunet. 1995. Viridans streptococcal bacteremia and viridans streptococcal shock syndrome in neutropenic patients: comparison between children and adults receiving chemotherapy or undergoing bone marrow transplantation. Clin. Infect. Dis. 20:476-477.
38. Matsushita, K., W. Fujimaki, H. Kato, T. Uchiyama, H. Igarashi, H. Ohkuni, S. Nagaoka, M. Kawagoe, S. Kotani, and H. Takada. 1995. Immunopathological activities of extracellular products of Streptococcus mitis, particularly a superantigenic fraction. Infect. Immun. 63:785-793.
39. Mogi, A., J. I. Nishi, M. Yoshinaga, H. Harada, S. Narahara, K. Kawakami, and I. Maruyama. 1997. Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases. Pediatr. Infect. Dis. J. 16:1140-1144.
40. Mrazova, M., A. Docze, E. Buckova, L. Bucko, M. Kacmarikova, E. Grey, J. Korcova, J. Koprnova, Z. Saboova, P. Beno, M. Karvaj, I. Svetlansky, A. Ondrus, J. Benca, M. Taziarova, B. Rudinsky, and V. Krcmery, Jr. 2005. Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes. Scand. J. Infect. Dis. 37:637-641.
41. Mullen, C. A., D. Petropoulos, W. M. Roberts, M. Rytting, T. Zipf, K. W. Chan, S. J. Culbert, M. Danielson, S. S. Jeha, J. F. Kuttesch, and K. V. Rolston. 1999. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 86:126-134.
42. Ohuoba, E. F., R. G. Kansal, R. T. Hayden, M. Kotb, and E. E. Adderson. 2006. Failure of viridans group streptococci causing bacteremia in pediatric oncology patients to express superantigens. J. Pediatr. Hematol. Oncol. 28:627-629.
43. Parkins, M. D., C. D. Sibley, M. G. Surette, and H. R. Rabin. 2008. The Streptococcus milleri group - an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Pediatr. Pulmonol. 43:490-497.
44. Poyart, C., G. Quesne, S. Coulon, P. Berche, and P. Trieu-Cuot. 1998. Identification of streptococci to species level by sequencing the gene encoding the manganese-dependent superoxide dismutase. J. Clin. Microbiol. 36:41-47.
45. Poyart, C., G. Quesne, and P. Trieu-Cuot. 2002. Taxonomic dissection of the Streptococcus bovis group by analysis of manganese-dependent superoxide dismutase gene (sodA) sequences: reclassification of 'Streptococcus infantarius subsp. coli' as Streptococcus lutetiensis sp. nov. and of Streptococcus bovis biotype 11.2 as Streptococcus pasteurianus sp. nov. Int. J. Syst. Evol. Microbiol. 52:1247-1255.
46. Razonable, R. R., M. R. Litzow, Y. Khaliq, K. E. Piper, M. S. Rouse, and R. Patel. 2002. Bacteremia due to viridans group streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin. Infect. Dis. 34:1469-1474.
47. Richter, S. S., K. P. Heilmann, C. L. Dohrn, F. Riahi, S. E. Beekmann, and G. V. Doern. 2008. Accuracy of phenotypic methods for identification of Streptococcus pneumoniae isolates included in surveillance programs. J. Clin. Microbiol. 46:2184-2188.
48. Richter, S. S., W. J. Howard, M. P. Weinstein, D. A. Bruckner, J. F. Hindler, M. Saubolle, and G. V. Doern. 2007. Multicenter evaluation of the BD Phoenix Automated Microbiology System for antimicrobial susceptibility testing of Streptococcus species. J. Clin. Microbiol. 45:2863-2871.
49. Rodríguez-Avial, I., C. Rodriguez-Avial, E. Culebras, and J. J. Picazo. 2005. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species. Antimicrob. Agents Chemother. 49:820-823.
50. Sibley, C. D., M. D. Parkins, H. R. Rabin, K. Duan, J. C. Norgaard, and M. G. Surette. 2008. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 105:15070-15075.
51. Stockheim, J. A., E. G. Chadwick, S. Kessler, M. Amer, N. Abdel-Haq, A. S. Dajani, and S. T. Shulman. 1998. Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children? Clin. Infect. Dis. 27:1451-1456.
52. Tazumi, A., Y. Maeda, C. E. Goldsmith, W. A. Coulter, C. Mason, B. C. Millar, M. McCalmont, J. Rendall, J. S. Elborn, M. Matsuda, and J. E. Moore. 2009. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). J. Antimicrob. Chemother. 64:501-506.
53. Whiley, R. A., D. Beighton, T. G. Winstanley, H. Y. Fraser, and J. M. Hardie. 1992. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J. Clin. Microbiol. 30:243-244.
54. Whiley, R. A., H. Fraser, J. M. Hardie, and D. Beighton. 1990. Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group". J. Clin. Microbiol. 28:1497-1501.
55. Whiley, R. A., L. M. Hall, J. M. Hardie, and D. Beighton. 1999. A study of small-colony, beta-haemolytic, Lancefield group C streptococci within the anginosus group: description of Streptococcus constellatus subsp. pharyngis subsp. nov., associated with the human throat and pharyngitis. Int. J. Syst. Bacteriol. 49:1443-1449.